News
BAYRY
11.26
-2.85%
-0.33
Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
TipRanks · 2d ago
Lufthansa publishes notice convening annual general meeting
Reuters · 3d ago
Goldman Sachs raises Bayer voting rights to 5.24% from 3.95%
Reuters · 3d ago
Kepler Capital Sticks to Their Buy Rating for Bayer (0P6S)
TipRanks · 3d ago
Bayer pushes for higher drug prices in talks with wealthier nations
Seeking Alpha · 3d ago
Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa
TipRanks · 3d ago
Bayer says Europe may need to pay more for medicines, FT reports
TipRanks · 3d ago
MEDIA-Bayer weighs U.S. pharma expansion as turnaround picks up speed - WSJ
Reuters · 3d ago
ORIC Pharma drops after early-stage trial data for prostate cancer therapy
Seeking Alpha · 3d ago
*Bayer Is in Negotiations for a Number of Pharma Deals, Unit President Says
Dow Jones · 3d ago
*Bayer Pharma President Says Business Is Looking at U.S. Manufacturing Expansion
Dow Jones · 3d ago
*Bayer Is Looking at Pharma Acquisitions, Unit President Says
Dow Jones · 3d ago
*Bayer Pharma President Rules Out Asset Sales Until Recent Launches Make Progress
Dow Jones · 3d ago
Bayer Weighs U.S. Pharma Expansion as Turnaround Picks Up Speed -- Interview
Dow Jones · 3d ago
*Bayer Pharma President Says Business Has Shifted to U.S.-Centric Approach
Dow Jones · 3d ago
Bayer targets mid-single-digit pharma growth from 2027, 30% margin by 2030 at Media Day
Reuters · 3d ago
Goldman Sachs cuts Bayer voting rights stake to 3.95% from 5.20%
Reuters · 4d ago
DKSH Thailand expands Bayer partnership to commercialize endometriosis treatment nationwide
Reuters · 4d ago
DKSH Thailand, Bayer Thai expand partnership to commercialize endometriosis treatment
Reuters · 4d ago
Bayer names Nelson Ambrogio to lead US pharmaceuticals business from May 2026
Reuters · 4d ago
More
Webull provides a variety of real-time BAYRY stock news. You can receive the latest news about Bayer Aktien through multiple platforms. This information may help you make smarter investment decisions.
About BAYRY
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.